How Does the SRY Gene Govern Sex Determination?
Sex determination in mammalian embryonic development is a tightly coordinated process directed by genetic triggers and subsequent hormonal signaling. The initial developmental trajectory of the bipotential gonad hinges on the expression of the SRY gene located on the Y chromosome, which initiates testicular differentiation. Once this genetic cascade is activated, newly formed Sertoli and Leydig cells secrete key hormones, specifically Anti-Müllerian Hormone and testosterone, which direct male internal and external anatomical development. Without the SRY trigger, an alternative ovarian genetic program takes precedence, leading to female phenotypic sexual differentiation in the absence of testicular hormones.
The Bipotential Gonad and the Genetic Switch
During early mammalian embryogenesis, the gonadal primordium is bipotential, possessing the morphological capability to develop into either testes or ovaries. Along with the bipotential gonad, two pairs of rudimentary duct systems exist: the Wolffian (mesonephric) ducts and the Müllerian (paramesonephric) ducts.
The primary genetic trigger for testis development is the SRY (Sex-determining Region Y) gene, located on the short arm of the Y chromosome. SRY encodes a high-mobility group (HMG) box transcription factor. In humans and mice, the transient expression of SRY within a critical developmental window in somatic progenitor cells is necessary and sufficient to direct these cells down the Sertoli cell lineage.
Downstream Genetic Cascade: SOX9 and Antagonistic Signaling
The central role of the SRY transcription factor is to activate the autosomal gene SOX9 (SRY-box transcription factor 9). SRY binds to specific enhancer elements—such as TESCO (Testis-specific Enhancer of Sox9 Core)—synergistically with other factors including SF1 (Steroidogenic Factor 1, encoded by NR5A1).
Once activated, SOX9 initiates positive feedback loops:
- Autoregulation: SOX9 protein binds to its own regulatory sequences to sustain its expression long after SRY levels decline.
- Paracrine Signaling: SOX9 upregulates FGF9 (Fibroblast Growth Factor 9) and PTGDS (Prostaglandin D2 Synthase). FGF9 and PGD2 act via cell-surface receptors to recruit neighboring somatic cells into the Sertoli fate and reinforce SOX9 transcription across the gonad.
Concurrently, SOX9 represses the female-determining pathway. In the absence of SRY, transcription factors such as WNT4 and RSPO1 stabilize \(\beta\)-catenin, which upregulates FOXL2. This network actively represses SOX9 and directs the gonad toward ovarian development. Thus, primary sex determination represents a mutually antagonistic molecular switch between SOX9/FGF9 and WNT4/RSPO1/FOXL2.
Transition from Genetic Determination to Hormonal Differentiation
While primary sex determination (gonadal fate) is driven by cell-autonomous genetic cascades, secondary sex determination (internal ducts and external genitalia) is governed by hormonal cues produced by the differentiated gonad.
1. Anti-Müllerian Hormone (AMH)
Sertoli cells begin synthesizing and secreting Anti-Müllerian Hormone (AMH), a member of the Transforming Growth Factor-beta (TGF-\(\beta\)) superfamily. AMH binds to its type II receptor (AMHR2) on the mesenchyme surrounding the Müllerian ducts, inducing paramesonephric duct regression via apoptosis. This prevents the formation of the fallopian tubes, uterus, and upper vagina.
2. Testosterone and Leydig Cell Differentiation
Sertoli cells orchestrate the differentiation of interstitial somatic cells into fetal Leydig cells via desert hedgehog (DHH) and PDGF signaling. Fetal Leydig cells initiate androgen steroidogenesis, producing testosterone. Testosterone binds to the androgen receptor (AR) within the Wolffian duct system, promoting its stabilization and differentiation into the epididymides, vasa deferentia, and seminal vesicles.
3. Dihydrotestosterone (DHT) and External Genitalia
In target tissues such as the genital tubercle and urogenital sinus, testosterone is converted into the more potent androgen dihydrotestosterone (DHT) by the enzyme 5\(\alpha\)-reductase type 2. DHT mediates the virilization of external structures, resulting in penile formation, scrotal fusion, and prostate gland morphogenesis.
Summary of the Pathway
Primary mammalian sex determination depends on the transient transcription of SRY, which permanently switches the bipotential gonad toward the testicular pathway through robust SOX9 activation and WNT4 repression. Secondary sex characteristics subsequently depend on endocrine outputs: Sertoli-derived AMH induces Müllerian duct regression, while Leydig-derived androgens stabilize the Wolffian ducts and masculine external features.